These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 14059552

  • 1. PSEUDOHYPOPARATHYROIDISM WITH OSTEITIS FIBROSA CYSTICA AND IMPAIRED ABSORPTION OF CALCIUM.
    BELL NH, GERARD ES, BARTTER FC.
    J Clin Endocrinol Metab; 1963 Aug; 23():759-62. PubMed ID: 14059552
    [No Abstract] [Full Text] [Related]

  • 2. Pseudohypoparathyroidism with raised plasma alkaline phosphatase.
    Cohen RD, Vince FP.
    Arch Dis Child; 1969 Feb; 44(233):96-101. PubMed ID: 5304559
    [No Abstract] [Full Text] [Related]

  • 3. Renal resistance to parathyroid hormone with hyperphosphatemic osteomalacia and osteitis fibrosa. A case report.
    Milgram JW, Engh CA, Hamilton CR, Kammer GM.
    J Bone Joint Surg Am; 1974 Oct; 56(7):1493-500. PubMed ID: 4433369
    [No Abstract] [Full Text] [Related]

  • 4. HYPO-HYPERPARATHYROIDISM.
    COSTELLO JM, DENT CE.
    Arch Dis Child; 1963 Aug; 38(200):397-407. PubMed ID: 14058815
    [No Abstract] [Full Text] [Related]

  • 5. [ON THE FUNCTIONAL DIAGNOSIS OF THE SKELETON].
    GUIDERI R, CESARI L, FRUSCHELLI C, GENNARI C, BIANCHI V.
    Med Clin Sper; 1963 Aug; 13():1-38. PubMed ID: 14050302
    [No Abstract] [Full Text] [Related]

  • 6. ON THE ABNORMAL CALCIUM ABSORPTION IN SARCOIDOSIS. EVIDENCE FOR INCREASED SENSITIVITY TO VITAMIN D.
    BELL NH, GILL JR, BARTTER FC.
    Am J Med; 1964 Apr; 36():500-13. PubMed ID: 14142404
    [No Abstract] [Full Text] [Related]

  • 7. A comparison of vitamin D2 and D3 in New World primates. I. Production and regression of osteodystrophia fibrosa.
    Hunt RD, Garcia FG, Hegsted DM.
    Lab Anim Care; 1967 Apr; 17(2):222-34. PubMed ID: 4291877
    [No Abstract] [Full Text] [Related]

  • 8. Osteitis fibrosa cystica with renal parathyroid hormone resistance: a review of pseudohypoparathyroidism with insight into calcium homeostasis.
    Eubanks PJ, Stabile BE.
    Arch Surg; 1998 Jun; 133(6):673-6. PubMed ID: 9637471
    [Abstract] [Full Text] [Related]

  • 9. [ALBRIGHT'S HEREDITARY OSTEODYSTROPHY].
    SCHOENGUT L, CSERHATI E.
    Acta Paediatr Acad Sci Hung; 1963 Jun; 4():373-88. PubMed ID: 14121969
    [No Abstract] [Full Text] [Related]

  • 10. Pseudohypoparathyroidism with osteitis fibrosa cystica: direct demonstration of skeletal responsiveness to parathyroid hormone in cells cultured from bone.
    Murray TM, Rao LG, Wong MM, Waddell JP, McBroom R, Tam CS, Rosen F, Levine MA.
    J Bone Miner Res; 1993 Jan; 8(1):83-91. PubMed ID: 8427051
    [Abstract] [Full Text] [Related]

  • 11. [CALCIUM METABOLISM IN HYPOPARATHYROIDISM].
    MAZZUOLI GF, BIAGI E, COEN G.
    Folia Endocrinol; 1963 Aug; 16():363-84. PubMed ID: 14086617
    [No Abstract] [Full Text] [Related]

  • 12. KINETICS OF HUMAN CITRATE METABOLISM: STUDIES IN NORMAL SUBJECTS AND IN PATIENTS WITH BONE DISEASE.
    TASHJIAN AH, WHEDON GD.
    J Clin Endocrinol Metab; 1963 Oct; 23():1029-43. PubMed ID: 14067890
    [No Abstract] [Full Text] [Related]

  • 13. Parathyroid tumour with osteitis fibrosa cystica. Case report with review.
    THORLAKSON TK.
    Winnipeg Clin Q; 1962 Dec; 15():140-53. PubMed ID: 13984952
    [No Abstract] [Full Text] [Related]

  • 14. Normocalcemic primary hyperparathyroidism with osteitis fibrosa.
    Frame B, Foroozanfar F, Patton RB.
    Ann Intern Med; 1970 Aug; 73(2):253-7. PubMed ID: 5454261
    [No Abstract] [Full Text] [Related]

  • 15. Primary hyperparathyroidism: clinical and biochemical features.
    Mallette LE, Bilezikian JP, Heath DA, Aurbach GD.
    Medicine (Baltimore); 1974 Mar; 53(2):127-46. PubMed ID: 4361513
    [No Abstract] [Full Text] [Related]

  • 16. Renal resistance to parathyroid hormone with osteitis fibrosa: "pseudohypohyperparathyroidism".
    Frame B, Hanson CA, Frost HM, Block M, Arnstein AR.
    Am J Med; 1972 Mar; 52(3):311-21. PubMed ID: 5011390
    [No Abstract] [Full Text] [Related]

  • 17. Limitation by hyperphosphataemia of the "prophylactic" use of vitamin D metabolites in the treatment of osteitis fibrosa in patients on chronic haemodialysis.
    de Fremont JF, Sebert JL, Gueris J, Marie P, Coevoet B, Makdassi R, Lambrey G, Meunier P, Fournier A.
    Proc Eur Dial Transplant Assoc; 1979 Mar; 16():675-6. PubMed ID: 232918
    [No Abstract] [Full Text] [Related]

  • 18. [Albright's hereditary osteodystrophy and 2 of its clinical aspects, pseudo-hypoparathyroidism and pseudo-pseudo-hypoparathyroidism].
    NOUAILHAT F.
    Presse Med (1893); 1963 Jan 19; 71():121-2. PubMed ID: 13939063
    [No Abstract] [Full Text] [Related]

  • 19. Symptomatic skeletal disease in non-terminal renal failure.
    Ingham JP, Kleerekoper M, Stewart JH, Posen S.
    Med J Aust; 1974 Jun 01; 1(22):873-6. PubMed ID: 4546933
    [No Abstract] [Full Text] [Related]

  • 20. Biological activity of endogenous and exogenous calcitonin in patients with osteitis fibrosa and chronic renal failure.
    Cundy T, Heynen G, Paton S, Ledingham JG, Russell RG, Oliver DO, Kanis JA.
    Proc Eur Dial Transplant Assoc; 1978 Jun 01; 15():524-31. PubMed ID: 740683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.